Advertisement

Variabilities of Magnetic Resonance Imaging–, Computed Tomography–, and Positron Emission Tomography–Computed Tomography–Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning

      Purpose

      To investigate interobserver delineation variability for gross tumor volumes of primary lung tumors and associated pathologic lymph nodes using magnetic resonance imaging (MRI), and to compare the results with computed tomography (CT) alone– and positron emission tomography (PET)-CT–based delineations.

      Methods and Materials

      Seven physicians delineated the tumor volumes of 10 patients for the following scenarios: (1) CT only, (2) PET-CT fusion images registered to CT (“clinical standard”), and (3) postcontrast T1-weighted MRI registered with diffusion-weighted MRI. To compute interobserver variability, the median surface was generated from all observers' contours and used as the reference surface. A physician labeled the interface types (tumor to lung, atelectasis (collapsed lung), hilum, mediastinum, or chest wall) on the median surface. Contoured volumes and bidirectional local distances between individual observers' contours and the reference contour were analyzed.

      Results

      Computed tomography– and MRI-based tumor volumes normalized relative to PET-CT–based volumes were 1.62 ± 0.76 (mean ± standard deviation) and 1.38 ± 0.44, respectively. Volume differences between the imaging modalities were not significant. Between observers, the mean normalized volumes per patient averaged over all patients varied significantly by a factor of 1.6 (MRI) and 2.0 (CT and PET-CT) (P=4.10 × 10−5 to 3.82 × 10−9). The tumor-atelectasis interface had a significantly higher variability than other interfaces for all modalities combined (P=.0006). The interfaces with the smallest uncertainties were tumor-lung (on CT) and tumor-mediastinum (on PET-CT and MRI).

      Conclusions

      Although MRI-based contouring showed overall larger variability than PET-CT, contouring variability depended on the interface type and was not significantly different between modalities, despite the limited observer experience with MRI. Multimodality imaging and combining different imaging characteristics might be the best approach to define the tumor volume most accurately.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Giraud P.
        • Elles S.
        • Helfre S.
        • et al.
        Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
        Radiother Oncol. 2002; 62: 27-36
        • Vorwerk H.
        • Beckmann G.
        • Bremer M.
        • et al.
        The delineation of target volumes for radiotherapy of lung cancer patients.
        Radiother Oncol. 2009; 91: 455-460
        • Peulen H.
        • Belderbos J.
        • Guckenberger M.
        • et al.
        Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy.
        Radiother Oncol. 2015; 114: 361-366
        • Van der Put R.W.
        • Raaymakers B.W.
        • Kerkhof E.M.
        • et al.
        A novel method for comparing 3D target volume delineations in radiotherapy.
        Phys Med Biol. 2008; 53: 2149-2159
        • Bradley J.
        • Thorstad W.L.
        • Mutic S.
        • et al.
        Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
        Int J Radiat Oncol Biol Phys. 2004; 59: 78-86
        • Nestle U.
        • Hellwig D.
        • Schmidt S.
        • et al.
        2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer.
        Mol Imaging Biol. 2002; 4: 257-263
        • Apostolova I.
        • Wiemker R.
        • Paulus T.
        • et al.
        Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.
        Eur Radiol. 2010; 20: 1868-1877
        • Erdi Y.E.
        • Nehmeh S.A.
        • Pan T.
        • et al.
        The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
        J Nucl Med. 2004; 45: 1287-1292
        • Goerres G.W.
        • Kamel E.
        • Seifert B.
        • et al.
        Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system.
        J Nucl Med. 2002; 43: 1469-1475
        • Khalil A.
        • Bouhela T.
        • Carette M.F.
        Contribution of MRI in lung cancer staging.
        JBR-BTR. 2013; 96: 132-141
        • Beale R.
        • Slater R.
        • Hennington M.
        • et al.
        Pancoast tumor: Use of MRI for tumor staging.
        South Med J. 1992; 85: 1260-1263
        • Heelan R.T.
        • Demas B.E.
        • Caravelli J.F.
        • et al.
        Superior sulcus tumors: CT and MR imaging.
        Radiology. 1989; 170: 637-641
        • Rapoport S.
        • Blair D.N.
        • McCarthy S.M.
        • et al.
        Brachial plexus: Correlation of MR imaging with CT and pathologic findings.
        Radiology. 1988; 167: 161-165
        • Takasugi J.E.
        • Rapoport S.
        • Shaw C.
        Superior sulcus tumors: The role of imaging.
        J Thorac Imaging. 1989; 4: 41-48
        • Henzler T.
        • Schmid-Bindert G.
        • Schoenberg S.O.
        • et al.
        Diffusion and perfusion MRI of the lung and mediastinum.
        Eur J Radiol. 2010; 76: 329-336
        • Metcalfe P.
        • Liney G.P.
        • Holloway L.
        • et al.
        The potential for an enhanced role for MRI in radiation-therapy treatment planning.
        Technol Cancer Res Treat. 2013; 12: 429-446
        • Mori T.
        • Nomori H.
        • Ikeda K.
        • et al.
        Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: Comparison with positron emission tomography.
        J Thorac Oncol. 2008; 3: 358-364
        • Usuda K.
        • Zhao X.T.
        • Sagawa M.
        • et al.
        Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers.
        Ann Thorac Surg. 2011; 91: 1689-1695
        • Fleckenstein J.
        • Jelden M.
        • Kremp S.
        • et al.
        The impact of diffusion-weighted MRI on the definition of gross tumor volume in radiotherapy of non-small-cell lung cancer.
        PLoS One. 2016; 11: e0162816
        • Fotina I.
        • Lutgendorf-Caucig C.
        • Stock M.
        • et al.
        Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.
        Strahlenther Onkol. 2012; 188: 160-167
        • Hanna G.G.
        • Hounsell A.R.
        • O'Sullivan J.M.
        Geometrical analysis of radiotherapy target volume delineation: A systematic review of reported comparison methods.
        Clin Oncol (R Coll Radiol). 2010; 22: 515-525
        • Fitton I.
        • Steenbakkers R.J.
        • Gilhuijs K.
        • et al.
        Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors.
        Int J Radiat Oncol Biol Phys. 2008; 70: 1403-1407
        • Steenbakkers R.J.
        • Duppen J.C.
        • Fitton I.
        • et al.
        Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis.
        Int J Radiat Oncol Biol Phys. 2006; 64: 435-448
        • Kim H.S.
        • Park S.B.
        • Lo S.S.
        • et al.
        Bidirectional local distance measure for comparing segmentations.
        Med Phys. 2012; 39: 6779-6790
        • Werner-Wasik M.
        • Nelson A.D.
        • Choi W.
        • et al.
        What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.
        Int J Radiat Oncol Biol Phys. 2012; 82: 1164-1171
        • Lorensen W.E.
        • Cline H.E.
        Marching cubes: A high resolution 3D surface construction algorithm.
        in: 14th Annual Conference on Computer Graphics and Interactive Techniques. Association for Computing Machinery, New York1987: 163-169
        • Wu J.
        • Murphy M.J.
        • Weiss E.
        • et al.
        Development of a population-based model of surface segmentation uncertainties for uncertainty-weighted deformable image registrations.
        Med Phys. 2010; 37: 607-614
        • Gwynne S.
        • Spezi E.
        • Sebag-Montefiore D.
        • et al.
        Improving radiotherapy quality assurance in clinical trials: Assessment of target volume delineation of the pre-accrual benchmark case.
        Br J Radiol. 2013; 86: 20120398
        • Hamilton C.S.
        • Ebert M.A.
        Volumetric uncertainty in radiotherapy.
        Clin Oncol (R Coll Radiol). 2005; 17: 456-464
        • Van de Steene J.
        • Linthout N.
        • de Mey J.
        • et al.
        Definition of gross tumor volume in lung cancer: Inter-observer variability.
        Radiother Oncol. 2002; 62: 37-49
        • Bowden P.
        • Fisher R.
        • Mac Manus M.
        • et al.
        Measurement of lung tumor volumes using three-dimensional computer planning software.
        Int J Radiat Oncol Biol Phys. 2002; 53: 566-573
        • Senan S.
        • van Sornsen de Koste J.
        • Samson M.
        • et al.
        Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
        Radiother Oncol. 1999; 53: 247-255
        • Ciernik I.F.
        • Dizendorf E.
        • Baumert B.G.
        • et al.
        Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study.
        Int J Radiat Oncol Biol Phys. 2003; 57: 853-863
        • Dizendorf E.V.
        • Baumert B.G.
        • von Schulthess G.K.
        • et al.
        Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy.
        J Nucl Med. 2003; 44: 24-29
        • Erdi Y.E.
        • Rosenzweig K.
        • Erdi A.K.
        • et al.
        Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
        Radiother Oncol. 2002; 62: 51-60
        • Giraud P.
        • Grahek D.
        • Montravers F.
        • et al.
        CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.
        Int J Radiat Oncol Biol Phys. 2001; 49: 1249-1257
        • Mah K.
        • Caldwell C.B.
        • Ung Y.C.
        • et al.
        The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study.
        Int J Radiat Oncol Biol Phys. 2002; 52: 339-350
        • van Der Wel A.
        • Nijsten S.
        • Hochstenbag M.
        • et al.
        Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study.
        Int J Radiat Oncol Biol Phys. 2005; 61: 649-655
        • Vanuytsel L.J.
        • Vansteenkiste J.F.
        • Stroobants S.G.
        • et al.
        The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
        Radiother Oncol. 2000; 55: 317-324
        • Dewas S.
        • Bibault J.E.
        • Blanchard P.
        • et al.
        Delineation in thoracic oncology: A prospective study of the effect of training on contour variability and dosimetric consequences.
        Radiat Oncol. 2011; 6: 118
        • Orton M.D.
        • Chang M.G.
        • Moghanaki D.
        • et al.
        Target volume delineation variability and the effect of contouring training during stereotactic body radiation therapy (SBRT) planning for lung cancer.
        World J Surg Med Radiat Oncol. 2014; 3: 34-43

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.